ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SBTX Skinbiotherapeutics Plc

16.00
0.125 (0.79%)
22 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.125 0.79% 16.00 15.75 16.25 16.00 15.875 15.88 691,080 14:39:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0125 -12.80 35.89M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 15.88p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 19.50p.

Skinbiotherapeutics currently has 226,086,285 shares in issue. The market capitalisation of Skinbiotherapeutics is £35.89 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -12.80.

Skinbiotherapeutics Share Discussion Threads

Showing 27051 to 27071 of 27925 messages
Chat Pages: Latest  1093  1092  1091  1090  1089  1088  1087  1086  1085  1084  1083  1082  Older
DateSubjectAuthorDiscuss
22/10/2024
14:36
syme ponggggggggggggggggggggggggggggggggggggggggg
thevladslayer
22/10/2024
14:07
Ashman could invite O Hara out for a dinner meeting on the expense card. Order half a horse each and spuds

The fkn horse would be running in Beverley the following week

putinaire
22/10/2024
11:55
pinggggggggggggggggggggggggggggggggggggggggggggggggggggggggg
thevladslayer
22/10/2024
11:49
How much is the tax free expense card worth? Is the expense card itemised bill available?
putinaire
22/10/2024
11:45
I'd do tbe job for 30K per year with an share price bonus of 500K built in

Get paid if I deserve it

putinaire
22/10/2024
11:38
SYME directors shud be stoned not fkn paid

given their shareholders 99 pct losses

great to watch though

thevladslayer
22/10/2024
11:36
Come on, would you work for amount.?
sunshine today
22/10/2024
11:35
20's


lol

thevladslayer
22/10/2024
11:26
Pay him £40000 per year then to save the whining about tax. Do these guys want to contribute as little ro society as they do to PIs?
putinaire
21/10/2024
16:56
DYOR

Stuart J. Ashman (CEO)
In post 5.5yrs.
Remuneration £382,480 - £306,000 (2023, 20% reduction 2024).
Total from appointment approx. £1,800,000+/-.
Shares purchased: 125,000 (2020) paid £0.16 per share (total £20,000), 156,250 (2022) paid £0.16 per share (total £25,000).
Number of shares held 276,804.
Invested in company £45,000.
% holding: 0.121%.
Options held 5,189,444 at exercise price of £0.09 and £0.18.

Manprit Randhawa (CFO)
In post 2.3yrs.
Remuneration £261,480 - £209,100 (2023, 20% reduction 2024).
Total Remuneration from appointment approx. £500,000+/-.
Shares purchased: 156,250 (2022) paid £0.16 per share (total £25,000).
Number of shares held 153,165.
% holding: 0.067%.
Invested in company £25,000.

Martin Hunt (Non-Executive Chairman)
In post 8yrs.
Remuneration/fees £68,670 (2023).
Remuneration/fees from appointment £460,000+/-.
Shares held 466,667 (2018): Buy 93,750 (2022) paid £0.16 per share (total £15,000).
Number of shares held 560,417.
Invested in company £15,000.
% holding: 0.245%.
Options held 3,892,082 at exercise price of £0.09.

Cathy Prescott (Non-Executive Director)
In post 7.6yrs.
Remuneration/fees £41,011 (2023).
Remuneration/fees from appointment £215,000+/-.
Shares purchased: 56,112 (2019) paid £0.1782 (total £10,000): 62,500 (2020) paid £0.16 per share (total £10,000). 62,500 (2022) paid £0.16 per share (Total £10,000).
Number of shares held 181,112.
Invested in company £30,000.
% holding: 0.079%.

Danielle Bekker (Non-Executive Director)
In post 2.5yrs.
Remuneration/fees £25,000 (2023).
Remuneration from appointment £56,250+/-.
Shares purchased: 43,750 (2022) paid £0.16 per share (total £7,000).
Invested in company £7,000.
% holding: 0.019%.

theterrier
21/10/2024
15:52
20's soon


fact

thevladslayer
21/10/2024
15:23
I see nana is back from her friends funeral with her 3 pence worth of 15p buys again

Looks like a few more million need dumping this week

putinaire
Chat Pages: Latest  1093  1092  1091  1090  1089  1088  1087  1086  1085  1084  1083  1082  Older

Your Recent History

Delayed Upgrade Clock